Back to search

Ireland· IE-PA-EU/1/25/1960/001

Zemcelpro ≥ 0.23×106 viable CD34+ cells/mL/≥ 0.53×106 viable CD3+ cells/mL dispersion for infusion

A stammzellen aus nabelschnurblut product containing haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1r, 4r)-n1-(2-benzyl-7-(2-methyl-2h-tetrazol-5-yl)-9h-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate, registered in Ireland by Cordex Biologics International Limited. The same ATC class is registered in 8 of our 19 countries.

ATC B05AX04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedZemcelpro ≥ 0.23×106 viable CD34+ cel…ATCB05AX04REGISTER NO.IE-PA-EU/1/25/1960/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Stammzellen aus nabelschnurblut is registered in 8 of 19 countries.

Countries holding a registration under ATC B05AX04 (stammzellen aus nabelschnurblut), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose

Stammzellen aus nabelschnurblut · ATC B05AX04

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
Manufacturer
Cordex Biologics International Limited
Country
Ireland (IE)
ATC code
B05AX04
ATC class
Stammzellen aus Nabelschnurblut
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/25/1960/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2960a698-fc21-44bf-91ae-62af181efa88
GET /v1/drugs/2960a698-fc21-44bf-91ae-62af181efa88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersion for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B05AX04"
  ],
  "strength": null,
  "pa_number": "EU/1/25/1960/001",
  "substances": [
    "Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "25/08/2025",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about stammzellen aus nabelschnurblut.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.